Spotlight Medical Announces Publication in Journal of Clinical Oncology Validating AI Pathology Assay That Identifies Low-Risk Subgroup Within Clinically High-Risk Early ER+/HER2- Breast Cancer The ...

Spotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism that holds power to account and drives positive change in Pennsylvania. Sign ...

PARIS, June 27, 2024--(BUSINESS WIRE)--Spotlight Medical, spinoff of Institut Curie, proudly announced its official launch. This innovative startup aims to transform cancer treatment using advanced ...

Updates: On Jan. 31, 2023, Ed Mahon published a data-driven investigation using more than a million records he obtained from the Department of Health through this litigation. As he wrote in a ...

It’s the third investigation based on data Spotlight PA obtained through litigation with free legal support from an RCFP attorney. In December, Spotlight PA published an investigation revealing that a ...

Spotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism that holds power to account and drives positive change in Pennsylvania. Sign ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Spotlight PA is an independent, nonpartisan newsroom powered by The Philadelphia Inquirer in partnership with PennLive/The Patriot-News, TribLIVE/Pittsburgh Tribune-Review, and WITF Public Media. Sign ...

PARIS--(BUSINESS WIRE)--Spotlight Medical today announced that the Journal of Clinical Oncology has published a peer-reviewed study describing a clinicopathologic assay that identifies a sizeable ...

The assay identifies a biologically low-risk subgroup within clinically high-risk patients, with outcomes similar to stage I disease, potentially sparing 30,000 women each year from unnecessary ...